Birmingham, West Midlands -- (SBWIRE) -- 01/09/2014 -- Value Penny Stocks issues special report on NuPathe Inc (NASDAQ:PATH), DryShips Inc. (NASDAQ:DRYS), Athersys, Inc. (NASDAQ:ATHX), Zogenix, Inc. (NASDAQ:ZGNX).
NuPathe Inc (NASDAQ:PATH) ended its recent business day with the gain of 35.60% and closed at the price of $4.38 after opening at $4.37. The stock traded during its last trading session with the total volume of 7,348,894 shares, as compared to its average volume of 654,604.00 million shares. NuPathe Inc., a specialty pharmaceutical company, focuses on the development and commercialization of branded therapeutics for neurological and psychiatric disorders. The company’s lead product is Zecuity, which is a sumatriptan iontophoretic transdermal system used for the acute treatment of migraine with or without aura in adults.
For How Long PATH will Fight for Profitability? Read This Trend Analysis report
DryShips Inc. (NASDAQ:DRYS) remained among the day decliners and traded with volume of 15,068,654 shares in the last session, as compared to average volume of 15.72 million shares. In comparison with 52 week range of $1.65 - $5.00, it faced lowest price of $4.02 during the last trading session whereas its day highest price was $4.2. The company’s total market capitalization is $1.65 billion, along with 403.76 million shares outstanding. DryShips Inc. owns drybulk carriers and tankers that operate worldwide. The company, through its majority owned subsidiary, Ocean Rig, owns and operates 10 offshore ultra deepwater drilling units.
Has DRYS Found The Bottom And Ready To Gain Momentum? Find Out Here
Athersys, Inc. (NASDAQ:ATHX) showed 7,083,773 shares in volume during the last trading session, while the average trading volume remained 1.65 million shares. The stock kicked off its trading session at $3.20 and closed at $3.92 after mounting 524.05%. Athersys, Inc, a biotechnology company, focuses on the research and development in the field of regenerative medicine. The company’s lead platform product, MultiStem, an allogeneic stem cell product, which was evaluated in two completed Phase I clinical trials and is under two ongoing Phase II clinical trials for treating a range of diseases and various application in the field of clinical regenerative medicine.
Will ATHX Continue To Move Higher? Find Out Here
Zogenix, Inc. (NASDAQ:ZGNX) stock traded during its last trading session with the total traded volume of 14,883,887 shares versus its average volume of 1.90 million shares. The company opened its trade at the price of $3.33 and its closing price was $3.88 after gaining 16.52% for the day. Zogenix, Inc., a pharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system disorders and pain. Its commercial product includes Sumavel DosePro (sumatriptan injection).
Why Should Investors Buy ZGNX After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)